FDA Inspection 1076629 — Romark Global Pharma, LLC
The FDA completed an inspection of Romark Global Pharma, LLC on Dec 20, 2018 in Dorado, PR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dorado, PR (United States)